ホーム > 鈴木 裕之/ Suzuki, Hiroyuki

鈴木 裕之

ALUMNI 2025年3月現在、筑波大学が主たる所属機関ではありません

Suzuki, Hiroyuki

東北大学 , 大学院医学系研究科 , 准教授
Tohoku University , Graduate School of Medicine , Associate Professor

http://www.md.tsukuba.ac.jp/epatho/

http://www.md.tsukuba.ac.jp/younginit/

シグナル伝達の異常に起因した疾患 を治療する創薬開発に向けた研究
シグナル伝達と疾患リサーチユニット
Research for drug discovery to treat diseases caused by abnormal cellular signaling

2017-05-16

金保 安則 加藤 光保 熊谷 嘉人 高橋 智 渋谷 彰 渋谷 和子 入江 賢児 鈴木 裕之 船越 祐司 新開 泰弘
オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
  1. 1. A novel anti-mouse CXCR1 monoclonal antibody, Cx1Mab-8, demonstrates nanomolar affinity in flow cytometry. Guanjie Li; Hiroyuki Suzuki; Tomohiro Tanaka; Hiroyuki Satofuka (+1 著者) Yukinari Kato
      Biochemistry and biophysics reports 42: 101965 (2025)
  2. 2. A novel anti-mouse CCR7 monoclonal antibody, C7Mab-7, demonstrates high sensitivity in flow cytometry, western blot, and immunohistochemistry. Hiroyuki Satofuka; Hiroyuki Suzuki; Tomohiro Tanaka; Rena Ubukata (+6 著者) Yukinari Kato
      Biochemistry and biophysics reports 41: 101948 (2025)
  3. 3. THG-1/TSC22D4 promotes interleukin-1 signaling through stabilization of TRAF6 in squamous cell carcinoma. Yasuhito Okano; Hiroyuki Suzuki; Yukihide Watanabe; Mohammed Abdelaziz (+14 著者) Mitsuyasu Kato
      Molecular cancer research : MCR (2025)
  4. 4. Antitumor Activities of a Humanized Cancer-Specific Anti-HER2 Monoclonal Antibody, humH2Mab-250 in Human Breast Cancer Xenografts. Mika K Kaneko; Hiroyuki Suzuki; Tomokazu Ohishi; Takuro Nakamura (+2 著者) Yukinari Kato
      International journal of molecular sciences 26: (2025)
  5. 5. Development of specific anti-mouse atypical chemokine receptor 4 monoclonal antibodies. Miu Hirose; Hiroyuki Suzuki; Rena Ubukata; Tomohiro Tanaka (+1 著者) Yukinari Kato
      Biochemistry and biophysics reports 40: 101824 (2024) Semantic Scholar
  6. 6. A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models. Tomohiro Tanaka; Hiroyuki Suzuki; Tomokazu Ohishi; Mika K KanekoYukinari Kato
      Cells 13: (2024) Semantic Scholar
  7. 7. A Cancer-Specific Anti-Podoplanin Monoclonal Antibody, PMab-117-mG2a Exerts Antitumor Activities in Human Tumor Xenograft Models Tomohiro Tanaka; Hiroyuki Suzuki; Tomokazu Ohishi; Mika K. KanekoYukinari Kato
      Cells 13: 1833 (2024) Semantic Scholar
  8. 8. Antitumor activities of anti‑CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer Kenichiro Ishikawa; Hiroyuki Suzuki; Tomokazu Ohishi; Takuro Nakamura (+7 著者) Yukinari Kato
      Oncology Reports 52: (2024) Semantic Scholar
  9. 9. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas Kenichiro Ishikawa; Hiroyuki Suzuki; Tomokazu Ohishi; Guanjie Li (+5 著者) Yukinari Kato
      International Journal of Molecular Sciences 25: 9190 (2024) Semantic Scholar
  10. 10. Anti-HER2 Cancer-Specific mAb, H2Mab-250-hG1, Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab. Hiroyuki Suzuki; Tomokazu Ohishi; Tomohiro Tanaka; Mika K KanekoYukinari Kato
      International journal of molecular sciences 25: (2024) Semantic Scholar
  11. 11. Development of Sensitive Anti-Mouse CCR5 Monoclonal Antibodies Using the N-Terminal Peptide Immunization. Rena Ubukata; Hiroyuki Suzuki; Tomohiro Tanaka; Guanjie Li (+1 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy (2024) Semantic Scholar
  12. 12. Development of a Sensitive Anti-Mouse CCR5 Monoclonal Antibody for Flow Cytometry. Hiroyuki Suzuki; Tomohiro Tanaka; Guanjie Li; Tsunenori Ouchida (+1 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy (2024) Semantic Scholar
  13. 13. Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C44Mab-108) Using Enzyme-Linked Immunosorbent Assay Hiroyuki Suzuki; Mayuki Tawara; Aoi Hirayama; Nohara Goto (+2 著者) Yukinari Kato
      Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 43: 85 (2024)
  14. 14. PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody. Tsunenori Ouchida; Guanjie Li; Hiroyuki Suzuki; Miyuki Yanaka (+4 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy 43: 53 (2024) Semantic Scholar
  15. 15. Cx1Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry. Guanjie Li; Tomohiro Tanaka; Tsunenori Ouchida; Mika K Kaneko (+1 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy 43: 59 (2024) Semantic Scholar
  16. 16. Cx3Mab-4: A Novel Anti-Mouse CXCR3 Monoclonal Antibody for Flow Cytometry. Tsunenori Ouchida; Yu Isoda; Tomohiro Tanaka; Mika K Kaneko (+1 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy (2024)
  17. 17. Epitope Mapping of an Anti-Mouse CD39 Monoclonal Antibody Using PA Scanning and RIEDL Scanning. Yuki Okada; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K KanekoYukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy (2024) Semantic Scholar
  18. 18. Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem-immunoreceptor tyrosine-based activation motif. Tomokazu Kimura; Yukari Okita; Yoshiyuki Nagumo; Jas Min Chin (+6 著者) Mitsuyasu Kato
      Pathology international (2024) Semantic Scholar
  19. 19. C8Mab-21: A Novel Anti-human CCR8 Monoclonal Antibody for Flow Cytometry Tomohiro Tanaka; Hiroyuki Suzuki; Guanjie Li; Mika K KanekoYukinari Kato
      (2024)
  20. 20. Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies Takao Arimori; Emiko Mihara; Hiroyuki Suzuki; Tomokazu Ohishi (+3 著者) Yukinari Kato
      Structure (2024) Semantic Scholar
1 2 3 … 9
  1. 1. あなたのラボから薬を生み出すアカデミア創薬の実践 : all Japan体制の先端技術支援を利用した創薬の最前線 善光, 龍哉; 辻川, 和丈 (担当:分担執筆, 範囲:CBIS法による高感度抗体の作製)
    羊土社 2024年2月 (ISBN: 9784758104166)
  2. 2. がんゲノム医療時代の分子腫瘍学 鈴木裕之; 後藤のはら; 加藤光保 (担当:分担執筆, 範囲:TGF-β経路)
    文光堂 2022年4月
  3. 3. 炎症メディエーター TGF-β 鈴木,裕之; 青山,知恵; 加藤,光保 (担当:共著)
    日本臨床 2009年5月
  4. 4. TGF-betaシグナル伝達系とがん治療 鈴木裕之; 中条友香; 加藤光保 (担当:監修)
    南山堂 2008年9月
  5. 5. TGF-βシグナル伝達とがん治療 鈴木裕之; 中条友香; 加藤光保 (担当:分担執筆)
    がんの分子標的治療 2008年6月
  6. 6. Negative regulation of the TGF-β family signal pathway by inhibitory Smads and their involvement in cancer and fibrosis. Itoh S; Suzuki H; Itoh F; Miyazono K; Kato M (担当:共著)
    Humana Press Inc. 2008年
  7. 7. IGFBP 鈴木裕之; 加藤光保 (担当:監修)
    サイトカイン・増殖因子用語ライブラリー / 羊土社 2005年3月
  8. 8. TGF-betaシグナルと疾患 鈴木裕之; 宮園浩平 (担当:監修)
    シグナル伝達研究2003 シグナル伝達研究2003 羊土社 2003年1月

 1,504 total views